Description

Book Synopsis
The Pharmacological Guide to Montelukast opens by presenting the most recent updates on the improvement of montelukast stability and bioavailability, along with some innovative formulations produced by this research. Montelukast is a leukotriene modifier with bronchoprotective and anti-inflammatory actions frequently used in asthma management. As such, the authors go on to assess the impact of the addition of montelukast to ongoing asthma treatment in terms of improvement in clinical parameters, symptom control and quality of life. The closing chapter focuses on leukotrienes, formed by leukocytes, which are inflammatory mediators that play an active role in early and late-phase immune response. This group includes montelukast, zafirlukast and prankulast.

Table of Contents
PrefaceMontelukast Encapsulation at the Micro, Nano and Molecular ScaleMontelukast as Add-On Therapy to Asthma Treatment Improves Symptom Control and Quality of LifeThe Efficacy of Montelukast in the Treatment of Allergic RhinitisIndex.

The Pharmacological Guide to Montelukast

    Product form

    £62.04

    Includes FREE delivery

    RRP £72.99 – you save £10.95 (15%)

    Order before 4pm tomorrow for delivery by Mon 29 Jun 2026.

    A Paperback / softback by SÃ,ren C. Dam

    1 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of The Pharmacological Guide to Montelukast by SÃ,ren C. Dam

      Publisher: Nova Science Publishers Inc
      Publication Date: 01/08/2022
      ISBN13: 9781536163940, 978-1536163940
      ISBN10: 1536163945
      Also in:
      Pharmacology

      Description

      Book Synopsis
      The Pharmacological Guide to Montelukast opens by presenting the most recent updates on the improvement of montelukast stability and bioavailability, along with some innovative formulations produced by this research. Montelukast is a leukotriene modifier with bronchoprotective and anti-inflammatory actions frequently used in asthma management. As such, the authors go on to assess the impact of the addition of montelukast to ongoing asthma treatment in terms of improvement in clinical parameters, symptom control and quality of life. The closing chapter focuses on leukotrienes, formed by leukocytes, which are inflammatory mediators that play an active role in early and late-phase immune response. This group includes montelukast, zafirlukast and prankulast.

      Table of Contents
      PrefaceMontelukast Encapsulation at the Micro, Nano and Molecular ScaleMontelukast as Add-On Therapy to Asthma Treatment Improves Symptom Control and Quality of LifeThe Efficacy of Montelukast in the Treatment of Allergic RhinitisIndex.

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account